• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    松

    松山赤十字病院

    Matsuyama Red Cross Hospital
    EST. 1913
    1,077论文总数
    2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1077)

    年份
    起
    –
    止
    排序
    1Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma with Liver Metastasis at Initial Diagnosis: a Nationwide Multicenter Study.
    Daisuke Hashimoto,Tsukasa Ikeura,Aya Maekawa,Takayoshi Nakajima,Keinosuke Ishido,Aoi Hayasaki,Toshimichi Asano,Masamichi Hayashi,Isaku Yoshioka,Hiromichi Ishii, Akifumi Kimura,Hideki Motobayashi,

    With recent advances in chemotherapy for unresectable pancreatic ductal adenocarcinoma (PDAC) with liver metastasis (LM), attempts have been made to resect the primary tumor in patients showing favorable responses to anti-cancer treatment (so-called “conversion surgery”; CS). This study aimed to clarify the outcomes of CS for PDAC with LM in a nationwide multicenter study. This retrospective, multicenter study was conducted as a project study of the Japan Pancreas Society and included patients with PDAC with LM at initial diagnosis, diagnosed radiologically or intraoperatively (occult LM), who underwent CS after at least 4 months of chemotherapy between 2010 and 2022. Survival outcomes and prognostic factors were analyzed. 90 patients were enrolled from 31 Japanese institutions. Median duration of preoperative chemotherapy was 10.4 (range, 4.2–58.5) months, and gemcitabine plus nab-paclitaxel was the most common first-line regimen, followed by folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin. Liver metastasectomy was performed in 27 patients (30

    2026Journal of Gastroenterology(2026)引用:35
    引用
    AI阅读
    加入学术空间
    2Drug-Coated Balloon Versus Drug-Eluting Stent for Femoropopliteal Lesions: A 3-Year Propensity Score-Matched Analysis.
    Osamu Iida,Mitsuyoshi Takahara,Yoshimitsu Soga,Yusuke Tomoi,Daizo Kawasaki,Masahiko Fujihara,Amane Kozuki,Akiko Tanaka,Yasutaka Yamauchi,Kazuki Tobita,Terutoshi Yamaoka,Shigeo Ichihashi,

    OBJECTIVE:While drug-eluting treatment is a first-line therapy for femoropopliteal (FP) lesions, long-term comparative data between drug-eluting stents (DES) and drug-coated balloons (DCB) in real-world practice are scarce. We aimed to compare the 3-year outcomes of DES versus DCB for symptomatic FP disease. METHODS:We conducted a retrospective analysis of the CILANTRO study, a multicenter registry combining data from the CAPSICUM, POPCORN, and POPCORN Type R studies. Patients treated with either DES or DCB for symptomatic FP lesions were included. To minimize selection bias, we performed 1:1 propensity score matching. The primary outcome was clinically driven target lesion revascularization (TLR), while secondary outcomes included restenosis. RESULTS:A total of 2651 patients treated with DCB and 972 with DES were identified. Propensity score matching extracted 912 pairs with well-balanced baseline characteristics. The median follow-up period was 31.6 months. The 3-year rate of TLR was not significantly different between the DCB and DES groups (23.3% vs. 18.8%; hazard ratio, 1.19 [95% confidence interval, 0.93-1.53]; p = 0.16). Interaction analysis revealed that a more marked increased risk of TLR in the DCB group in patients with semi-compliant balloon use or without non-compliant balloon use (p = 0.017 and 0.018). The 3-year rate of restenosis was significantly higher in the DCB group than in the DES group (38.1% vs. 26.3%; hazard ratio, 1.77 [1.43-2.19]; p < 0.001). CONCLUSIONS:In this propensity score-matched analysis, the 3-year rate of TLR was not significantly different between DCB and DES, although DES demonstrated lower restenosis rate. Nevertheless, DCB remains a clinically viable option, and our sub-analysis suggests that balloon selection for pre-dilatation may influence its efficacy.

    2026Catheterization and cardiovascular interventions official journal of the Society for Cardiac Angiog...(2026)
    引用
    AI阅读
    加入学术空间
    3Observer Agreement in Sonographic Glandular Tissue Component Classification and Sonographic Breast Density Assessment: a Multi-Institutional Study
    Takayoshi Uematsu,Ayumi Izumori,Kazutaka Nakashima,Satoko Abe, Yoichi Ishibe, Sachiko Isobe,Fuyo Kimura,Yumi Kokubu,Kazuaki Nakashima, Mikiko Nishikawa, Akina Seki, Yasuko Uchida,

    The sonographic glandular tissue component (GTC) is a potential imaging biomarker for stratifying breast cancer risk in women with dense breasts. This study evaluated the reproducibility, reliability, and clinical applicability of GTC classification and GTC-based sonographic breast density assessment in a multicenter observer study. Fifteen readers (nine physicians and six sonographers) from 12 institutions independently assessed 100 paired ultrasound images twice, 1 month apart, with the dataset rearranged for the second reading. GTC was qualitatively classified into four categories according to its estimated proportion within the fibroglandular tissue (FGT): minimal, mild, moderate, and marked; minimal/mild were grouped as low GTC and moderate/marked as high GTC. Sonographic breast density was categorized as sonographic dense breast (high GTC), sonographic non-dense breast (visible fat lobules), or intermediate, with intermediate cases further divided into high or low categories using an FGT-to-FAT (subcutaneous and retromammary fat) ratio cutoff of 1. Interobserver and intraobserver agreement was evaluated using κ statistics. Substantial interobserver agreement was observed for the four-class GTC classification, the two-class GTC classification, and sonographic breast density assessment. Intraobserver agreement was moderate for the four-class GTC classification and substantial for the two-class GTC classification and sonographic breast density assessment. The majority-vote sonographic breast density assessment showed substantial agreement with the mammographic ground truth, whereas individual-reader assessments showed moderate concordance with mammographic breast density both overall and in intermediate-density breasts. No significant differences in agreement were observed between physicians and sonographers. Substantial interobserver agreement and moderate-to-substantial intraobserver agreement support the reproducibility and reliability of GTC classification and GTC-based sonographic breast density assessment.

    2026Journal of Medical Ultrasonics(2026)
    引用
    AI阅读
    加入学术空间
    4ANALYSIS OF RISK FACTORS OF ADJACENT VERTEBRAL FRACTURE AFTER BALLOON KYPHOPLASTY INCLUDING TRUNK MUSCLES
    N. Sumiyoshi, R. Kajiwara, H. Omae, S. Oshima, A. Eguchi, N. Suga, M. Kanemitsu, H. Miyazaki, Y. Omori
    2026OSTEOPOROSIS INTERNATIONAL(2026)
    引用
    AI阅读
    加入学术空间
    5Robotic-Assisted Sigmoidectomy with D3 Lymphadenectomy for Sigmoid Colon Cancer in a Patient with Situs Inversus Totalis: A Case Report.
    Kazuhito Minami, Shojiro Kawano, Tomohiro Furukawa, Yuriko Tsutsui, Koichi Kimura, Yoshinari Nobutou, Hiroko Yano, Yuichiro Kajiwara,Ryosuke Minagawa,Takashi Nishizaki

    INTRODUCTION:Situs inversus totalis (SIT) is a rare congenital anomaly characterized by complete mirror-image transposition of thoracic and abdominal organs. Although laparoscopic colectomy in SIT has been increasingly reported, the reversed anatomy and inherent limitations of laparoscopy make such procedures technically demanding. Robotic-assisted surgery may overcome these issues by providing enhanced ergonomics and intuitive instrument control, yet reports in SIT remain scarce. CASE PRESENTATION:A 51-year-old man with SIT presented with anal bleeding and was diagnosed with sigmoid colon cancer. Preoperative CT confirmed complete visceral inversion without distant metastasis. Robotic-assisted sigmoidectomy with D3 lymphadenectomy was performed using the da Vinci Xi surgical system. A patient-specific port configuration was designed based on preoperative imaging, minimized arm collisions, and optimized instrument mobility. The procedure was uneventful, with an operative time of 232 minutes and minimal blood loss. The patient was discharged on POD 7 without complications. Histopathological examination revealed pT3, pN1a, cM0, Stage IIIB adenocarcinoma. CONCLUSIONS:This case demonstrates that robotic-assisted colectomy can effectively overcome the ergonomic and technical challenges posed by SIT. Patient-specific port mapping, guided by preoperative imaging, is essential to maximize the benefits of robotic technology. Furthermore, this report contributes to the limited evidence supporting robotic colectomy as a feasible and advantageous approach for patients with SIT.

    2026Surgical case reports(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1077 篇论文

    合作机构(100)

    九州大学合作论文 206
    爱媛大学合作论文 87
    大阪大学合作论文 76
    Kokura Memorial Hospital合作论文 73
    Kansai Rosai Hospital合作论文 66
    愛媛県立中央病院合作论文 60
    京都大学合作论文 53
    福冈大学合作论文 41
    东京大学合作论文 39
    Hamanomachi Hospital合作论文 35

    机构统计